IRulya Therapeutics IRLA

IRulya Therapeutics updates corporate presentation

Item 7.01 Investor disclosure

Form
8-K
Filed
Importance
Routine
  1. Posted Corporate Presentation on October 2026
  2. Presentation available at ir.irulya.com
  3. CFO signed filing

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Get an email when IRulya Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.